Buy CJC-1295 no DAC Peptide in Australia

Choose strength: 2 MG

2mg$74.995mg$94.9910mg$109.99

Buy CJC-1295 no DAC in Australia from Macropus Peptides in 2mg, 5mg and 10mg research vials, all priced and ready to order. Also known as Mod GRF 1-29, it is the first 29 amino acids of growth hormone releasing hormone, altered at four positions that slow enzyme breakdown, and without the albumin-binding linker it acts briefly, giving a clean pulse at the pituitary GHRH receptor. Vials contain freeze-dried peptide, sealed and labelled with name, strength, lot number and storage temperature, and the certificate of analysis for each lot is available to buyers. For studies that pair it with a ghrelin receptor agonist, our CJC-1295 and Ipamorelin blend and matching starter kits are stocked beside it. Add bacteriostatic water at checkout and the order ships from local Australian stock to any address in the country. CJC-1295 no DAC is supplied only for in-vitro research to adults 18 and over, not for human or veterinary use.

Compound	CJC-1295 no DAC
Amount	2 mg
Form	Lyophilised powder
Category	Growth hormone research
Storage	-20 °C, protect from light
Testing	HPLC purity 98% or higher and mass spectrometry identity, every batch
Certificate of analysis	Available for every lot, matched to the lot number on the label

CJC-1295 no DAC 2mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Diluent added (mL)

Buy CJC-1295 no DAC Australia: Mod GRF 1-29 in 2mg, 5mg and 10mg Vials

Macropus Peptides supplies the short-acting form of this releasing hormone analogue in three priced fills, 2mg, 5mg and 10mg, as research-grade lyophilised powder made to one specification. It is a stabilised 29 amino acid fragment of growth hormone releasing hormone (GHRH), the most requested GHRH analogue in our range and the backbone of our most popular blend. Every lot is released on its own certificate, so the vial you order is traceable from label to batch.

CJC-1295 no DAC Australia: what the peptide is

Often sold under the name Mod GRF 1-29, short for modified growth hormone releasing factor 1-29, this peptide keeps the active opening section of human GHRH and changes four amino acids in it. A D-alanine at position 2 stops the enzyme DPP-4 from snipping off the front of the chain. Glutamine at position 8 avoids a slow chemical change called deamidation, alanine at 15 helps the chain hold its active shape, and leucine at 27 replaces a methionine that oxidises easily. There is no linker attached, which is the difference from the DAC version and the reason it acts for a short time. The finished molecule weighs about 3,370 daltons. No regulator has approved it as a medicine, so its role is purely experimental.

CJC 1295 no DAC peptide: how the short-acting analogue works in research

Like natural GHRH, the analogue binds the GHRH receptor on growth hormone producing cells of the anterior pituitary. The receptor raises cyclic AMP, which prompts the cell to release stored growth hormone and make more. Native GHRH, like Sermorelin as its unmodified 1-29 copy, loses its first two amino acids to DPP-4 within minutes; the D-alanine swap slows that cut, yet with no albumin anchor the free peptide still clears in a short window. Each addition therefore gives one pulse followed by a return to baseline. That on and off pattern mirrors the way the hypothalamus actually signals, so the peptide is used to study pulsatile release, how pituitary cells recover between signals, and how somatostatin tone shapes the gap between pulses.

The second common use is a two-receptor design. Growth hormone cells also carry the ghrelin receptor, which signals through calcium rather than cyclic AMP, and pressing both switches together gives a larger growth hormone response than either alone. Pairing this analogue with a short-acting ghrelin agonist such as Ipamorelin keeps both inputs pulsatile, which is why the premixed pairing of the two is one of the most searched combinations in pituitary research. The older hexapeptides GHRP-2 and GHRP-6 fill the same ghrelin-side slot when a design can tolerate their extra cortisol and prolactin activity.

Short-acting CJC-1295 research: what the studies show

The hormone it copies was isolated in 1982 from pancreatic tumours by two separate groups, published in Science and in Nature, work that also showed the first 29 amino acids carried the activity. The receptor for its usual partner, the growth hormone secretagogue receptor, was cloned in 1996 (Science), giving the two-receptor model its molecular basis. The modified 1-29 chain, with four stabilising swaps, is the scaffold on which the albumin-linked analogue of a 2005 Endocrinology report was built. A year later, healthy-adult data (Journal of Clinical Endocrinology and Metabolism, 2006) showed how much longer the linked version persisted, which remains the plainest published contrast between the two forms. Published work on the free peptide is summarised in our Mod GRF 1-29 research studies library.

CJC-1295 vial specifications and storage

Every vial is filled with dry lyophilised peptide and capped with a stopper and crimped aluminium seal. Its label records the peptide, milligram amount, production lot and storage temperature. Ask for the certificate of analysis by quoting the lot, and the report for that exact batch comes back to you. Keep unmixed stock frozen at -20 °C, in the dark, until a study begins; once reconstituted, hold it at 2 to 8 °C.

CJC-1295 no DAC price in Australia: single vial, blend or value pack

All three fills are priced outright in Australian dollars. Double the peptide of the 5mg fill for only a modest step up in price makes the 10mg vial by far the keenest unit cost; the 2mg size asks for the least money up front but costs most per milligram. For a two-receptor study, the premixed blend with Ipamorelin costs less than buying the two single 10mg vials, and a three-vial value pack of that blend lowers the unit price again.

CJC-1295 no DAC 10mg: the stocked research vial

This is the size most laboratories order, and ten milligrams carries a pulsatile study through its full run on one lot. Diluted in 2 mL it becomes a 5 mg per mL solution, 500 micrograms in every 0.1 mL; spread across 5 mL it drops to 2 mg per mL. Our Mod GRF starter kit pairs this exact vial with a 3 mL water bottle, ten half-millilitre insulin syringes and 20 swabs; taking 2 mL from that bottle leaves one millilitre in reserve.

Molar amounts matter when this analogue is combined with a ghrelin agonist. Ten milligrams of the 29 amino acid chain is about 3 micromoles, while ten milligrams of the five amino acid Ipamorelin is about 14 micromoles, so equal masses deliver nearly five times as many ghrelin-side molecules.

The 5mg CJC-1295 vial for mid-sized protocols

Half the content of the larger vial, the 5mg fill fits a shorter series or a single arm of a bigger design. Adding 2.5 mL brings it to 2 mg per mL, matching what the 10mg vial reaches in 5 mL, so both sizes can feed one volume sheet. With 2 mL it sits at 2.5 mg per mL.

The 2mg CJC-1295 vial for method checks

The smallest fill is for proving a method, checking that the peptide dissolves cleanly and the assay responds before a bigger order, and it is the sensible size for a one-off pulse experiment. Mixed with 1 mL it reaches 2 mg per mL; with 2 mL, 1 mg per mL. Per milligram it costs the most of the three, which is the trade for a small commitment.

Best place to buy CJC-1295 no DAC in Australia

• Sold online at macropuspeptides.com in 2mg, 5mg and 10mg, priced from $74.99
• Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
• A certificate of analysis for every lot, matched to the lot number printed on the label
• Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
• Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
• Payment by PayID or bank transfer, with your order ID as the reference

Buy CJC 1295 online: how to get the no DAC vial

• Select the 2mg, 5mg or 10mg vial
• If your design uses a ghrelin receptor agonist, add Ipamorelin as a separate vial or pick the premixed blend
• Pick up a bottle of reconstitution water in the same parcel, or take the starter kit
• Tick the age and research-purpose declarations when paying
• Record the lot number on arrival for certificate requests

CJC-1295 calculator: mixing the 2mg, 5mg and 10mg Mod GRF vials

Stock strength equals vial milligrams over millilitres of diluent. For the ten milligram fill, a single millilitre yields 10 mg per mL; two yield 5; four yield 2.5; five yield 2. The five milligram fill yields 2.5 in two millilitres and 2 in two and a half, and the two milligram fill yields 2 in one millilitre. Scale any result by 1,000 to read it as micrograms per millilitre. Bacteriostatic water for the mix can ride in the same box, in a 3, 10 or 30 millilitre bottle.

Is Mod GRF 1-29 (CJC-1295) available in Australia

It is, as a research-only chemical. No ARTG registration covers any product containing it, which rules out sale for human or animal use; our supply is for in-vitro work. The TGA's Poisons Standard lists growth hormone releasing factors, and entries change over time, so make sure you know how the current edition applies to your laboratory before ordering.

CJC-1295 for sale Australia wide: shipping to every state

Stock held onshore means Mod GRF orders reach Darwin, Adelaide, Melbourne, Canberra, Brisbane, Hobart, Sydney, Perth and country laboratories by domestic post alone. The long-acting DAC version sits alongside it for continuous-exposure arms, and the growth hormone peptide range adds Tesamorelin, the full-length GHRH analogue.

Questions about CJC-1295 no DAC